SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zota Health Care secures product registration licenses for two products in Kyrgyzstan

30 Dec 2024 Evaluate

Zota Health Care has received product registration licenses for two products namely ‘Zotamet-1000 (Metformin Tablets BP 1000 mg)’ and ‘CDTEL-40 (Telmisartan Tablets USP 40 mg)’  from the Department of Medicines And Medical Devices under the Ministry of Health of the Kyrgyz Republic, Kyrgyzstan.

It has received aforementioned product registration licenses for the validity period of five years; further, the same can be renewed after expiration. The company shall commence export of these products in Kyrgyzstan in a near term.

Zota Health Care manufactures and markets pharmaceutical formulations, nutraceutical, and ayurvedic medicines in India and internationally. 


Peers
Company Name CMP
Redington 219.10
Adani Enterprises 2145.00
Amrapali Industries 18.75
Rashi Peripheral 424.10
PDS 288.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×